Company intelligence / Profile preview

Pneuma Systems

Portsmouth, New Hampshire, United States

Ownership: Private
Development stage: Other

Overview

Pneuma Systems' PneumaFlow controller and administration sets have been accepted into the FDA Safer Technologies Program (STeP) for expedited review, with an aim to reduce complexity and safety incidents in infusion therapy. There are no published clinical trial results yet, but the system claims substantial innovation in precision, reliability, and safety for intravenous drug delivery.

Therapeutic areas: Other
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

West Pharmaceutical Services

Beyond the preview

Go deeper on Pneuma Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pneuma Systems.

Explore the full profile